EMBC News and Press, Embecta Corp. From 02/09/24

2024-02-09 10:42:06 ET Embecta Corp. (EMBC) Q1 2024 Earnings Call Transcript February 09, 2024, 08:00 AM ET Company Participants Pravesh Khandelwal - VP of IR Dev Kurdikar - President and CEO Jake Elguicze - CFO Conference Call Participants Kallum Tit...

2024-02-09 06:37:28 ET More on Embecta Embecta submits FDA application for type 2 diabetes insulin patch pump Embecta Non-GAAP EPS of $0.59 beats by $0.19, revenue of $281.9M beats by $10.35M Seeking Alpha’s Quant Rating on Embecta Historical earnings ...

PARSIPPANY, N.J., Feb. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), a global diabetes care company, today reported financial results for the three month period ended December 31, 2023. "Building on our performance during 2023, em...

Asics Corporation ADR (ASCCY) is expected to report for quarter end 2023-12-31 W. P. Carey Inc. REIT (WPC) is expected to report $1.16 for Q4 2023 Core Scientific, Inc. (CORZQ) is expected to report for Q4 2023 Essent Group Ltd. (ESNT) is expected to report $1.59 for Q4 2023 SAAB ...

PARSIPPANY, N.J., Feb. 07, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (embecta) (Nasdaq: EMBC) today announced that management will host one-on-one investor meetings on Tuesday, February 13, 2024, at the Cliff Lodge, Snowbird, UT. About embecta embecta is a global diabetes care company th...

PARSIPPANY, N.J., Jan. 24, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal first quarter 2024 financial results, provide an operational upd...

2024-01-17 04:20:00 ET Summary The beginning of every month is exciting for all dividend income investors as we look back at the previous month and see how much passive dividend income our portfolios generated. Looking back at my December totals, I see that my year-over-year progr...

2024-01-09 13:05:55 ET More on Embecta Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript Embattled Embecta Continues To Present Challenges To Shareholder Value Embecta Non-GAAP EPS of $0.59 beats by $0.19, revenue of $281.9M beats by $10.35M Seeking Alpha...

PARSIPPANY, N.J., Jan. 09, 2024 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced that it has submitted a 510(k) premarket filing to the U.S. Food and Drug Administration (FDA) for a proprietary...

2024-01-07 17:42:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...